Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Getting to the heart of cardiovascular outcomes in rheumatic disease Rob Volansky
-
- CVD risk reduction: How do you get this done? Leonard H. Calabrese, DO
- Big pharma and COVID-19: Balancing social commitments and profits Rob Volansky
- ACR gout guideline: Strong recommendation should be presented as evidence-based discussion Brian F. Mandell, MD, PhD, FACR, MACP
- Physically demanding jobs linked to increased odds of knee OA Jason Laday
- Ticagrelor linked to 29% lower risk for osteoarthritis than clopidogrel Jason Laday
- Vitamin D, omega-3 fatty acids supplements over 5 years fail to reduce knee pain Jason Laday
- Clinical observation pivotal to managing temporomandibular joint arthritis Rob Volansky
- Insight from 1918 flu pandemic, military ingenuity enabled ‘adapting quickly’ to COVID-19 Rob Volansky
-
- Patient wellness more reliant on 'lifestyle management' than biologic therapies Rob Volansky
- Adding colchicine to prevent gout flares while initiating allopurinol 'very cost effective' Jason Laday
- Hospital charges rise while mortality falls in systemic sclerosis with infection Jason Laday
- Sarilumab safe, effective in severe COVID-19 with minor lung consolidation Jason Laday
- Upadacitinib superior to methotrexate in treating rheumatoid arthritis Jason Laday
- Rituximab successfully re-induces remission after ANCA-associated vasculitis relapse Jason Laday